DIRECTOR, NATIONAL ACCOUNTS 3 of 3

Zydus Therapeutics (ZTI) is a clinical stage, specialty-focused bio-pharmaceutical company focused on developing transformative treatments to transform lives, starting with rare and serious liver diseases. Our purpose is simple, to empower people with the freedom to live healthier and more fulfilling lives, by unlocking new possibilities in life sciences and providing quality healthcare solutions. Our lead drug candidate, saroglitazar, is a dual peroxisome proliferator-activated receptor (PPAR) alpha / gamma agonist.

Saroglitazar is an investigational treatment which has received Fast Track designation and orphan drug designation from the US Food and Drug Administration (FDA) for the treatment of patients with primary biliary cholangitis (PBC). As a wholly owned subsidiary of Zydus Lifesciences, our pipeline is fueled by 1,300 researchers who are working with cutting-edge technologies to discover new medicines for tomorrow.

The opportunity

to empower people with the freedom to live healthier and more fulfilling lives is what makes a career with Zydus Therapeutics so rewarding. Our team is collaborative, innovative and adaptable. We are action-oriented and strive for excellence in all we do, all underpinned by respect, trust and integrity. We offer a wide variety of competitive benefits, services and support programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives If you are passionate about helping bring potential life-changing discoveries to patients, then you share our mission.

ROLE SUMMARY Reporting to the Executive Director, Payer Access, the Director of National Accounts is responsible for facilitating the introduction, education, and access /reimbursement of ZTI products within national/regional payers and PBMs across the Commercial, Medicare, and Medicaid books of business, as well as the Veteran’s Administration (VA), Dept. of Defense and other federal/state agencies or integrated delivery network accounts, as assigned.

Directors will be responsible for the development and execution of strategic account plans. Subsequent implementation of the strategy and tactics will be driven through alignment of the strategy with defining critical success factors, key performance indicators, and the supporting tactics for our products. This individual will need to work closely with patient services, distribution, sales, marketing, MSLs and commercial operations on a routine basis to ensure alignment in a fast-paced matrix environment.

RESPONSIBILITIES · Create and execute a business strategy and execution plan for assigned commercial/federal/state government payer markets with an objective to minimize access barriers through streamlined and transparent coverage resulting in smooth patient access to therapy · Drive education in coordination with commercial leadership and other Value & Access team members regarding commercial/federal/state marketplace activities and make recommendations for their pull through success in this marketplace to maximize appropriate use · Execute and support any necessary commercial/government contracts as necessary to optimize reimbursement /product access. · Responsible for staying current with the evolution of trends and policies related to the commercial/federal/state government access markets · Create and update business strategies and plans as needed. · Facilitate communication about this segment across all relevant stakeholders · Establish critical relationships with a variety of stakeholders within this segment · Establish Zydus Therapeutics as a strategic partner for commercial, federal and state customers. · Reactively respond to any identified coverage issues and market access challenges within a given payer segment · Lead and demonstrate the ability to expand or build long-term executive level account relationships with targeted accounts · Collaborate with brand and medical teams to continually improve relationships · Attend key trade meetings (ex.

PCMA, AMCP), POA’s and sales meetings · Develop internal triage process in collaboration with field leadership around coverage concerns including denials or appeals and a plan to remediate